Colony Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$3.08M Buy
3,747
+1,088
+41% +$895K 0.05% 280
2023
Q2
$1.91M Sell
2,659
-1,354
-34% -$973K 0.03% 351
2023
Q1
$3.3M Sell
4,013
-88
-2% -$72.3K 0.05% 277
2022
Q4
$2.96M Buy
4,101
+1,845
+82% +$1.33M 0.04% 310
2022
Q3
$1.55M Sell
2,256
-244
-10% -$168K 0.03% 364
2022
Q2
$1.48M Sell
2,500
-1,886
-43% -$1.12M 0.03% 370
2022
Q1
$3.06M Buy
4,386
+1,380
+46% +$964K 0.05% 305
2021
Q4
$1.9M Sell
3,006
-4,170
-58% -$2.63M 0.03% 331
2021
Q3
$4.34M Buy
7,176
+2,188
+44% +$1.32M 0.08% 195
2021
Q2
$2.79M Buy
4,988
+18
+0.4% +$10.1K 0.06% 262
2021
Q1
$2.35M Buy
4,970
+771
+18% +$365K 0.05% 283
2020
Q4
$2.03M Buy
4,199
+558
+15% +$270K 0.05% 273
2020
Q3
$2.04M Buy
3,641
+1,822
+100% +$1.02M 0.05% 267
2020
Q2
$1.13M Buy
1,819
+12
+0.7% +$7.48K 0.03% 328
2020
Q1
$882K Sell
1,807
-137
-7% -$66.9K 0.03% 355
2019
Q4
$730K Sell
1,944
-8,056
-81% -$3.03M 0.02% 460
2019
Q3
$2K Buy
+10,000
New +$2K ﹤0.01% 694
2017
Q2
Sell
-570
Closed -$221K 440
2017
Q1
$221K Sell
570
-65
-10% -$25.2K 0.02% 257
2016
Q4
$233K Buy
+635
New +$233K 0.03% 258
2016
Q1
Sell
-1,758
Closed -$954K 542
2015
Q4
$954K Buy
1,758
+46
+3% +$25K 0.09% 198
2015
Q3
$796K Sell
1,712
-9
-0.5% -$4.19K 0.09% 193
2015
Q2
$878K Buy
1,721
+103
+6% +$52.5K 0.09% 198
2015
Q1
$731K Buy
1,618
+648
+67% +$293K 0.08% 186
2014
Q4
$398K Buy
970
+520
+116% +$213K 0.04% 268
2014
Q3
$162K Hold
450
0.02% 329
2014
Q2
$127K Buy
450
+444
+7,400% +$125K 0.02% 253
2014
Q1
$2K Buy
+6
New +$2K ﹤0.01% 762